Understanding how collagen is broken down in the body

Allosteric control of collagen fibril degradation by matrix metalloprotease-1

NIH-funded research Arizona State University-Tempe Campus · NIH-10907837

This study is looking at how certain enzymes break down collagen, which is important for keeping our tissues healthy, to help us understand their role in skin and heart problems.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionArizona State University-Tempe Campus NIH-funded
Lab location1 site (Tempe, United States)
Project IDNIH-10907837 on NIH RePORTER

What this research studies

This research investigates the mechanisms by which specific enzymes, known as matrix metalloproteases (MMPs), degrade collagen fibrils, which are crucial for maintaining tissue integrity. Using advanced imaging techniques, the study aims to track the behavior of these enzymes on collagen fibrils to better understand their roles in various diseases, including skin conditions and cardiovascular issues. The research combines innovative single-molecule tracking, simulations, and animal studies to explore how MMP1 and MMP9 interact with collagen. By uncovering these mechanisms, the research seeks to provide insights into tissue remodeling processes that are vital for health and disease.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals with conditions involving collagen degradation, such as atherosclerosis or certain skin diseases.

Not a fit: Patients with conditions unrelated to collagen metabolism or those not experiencing tissue remodeling may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for conditions related to collagen degradation, such as atherosclerosis and skin diseases.

How similar studies have performed: Previous research has shown success in understanding collagen degradation mechanisms, but this specific approach using single-molecule tracking is relatively novel.

Where this research is happening

Tempe, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Atherosclerotic Cardiovascular Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.